Board of Directors
The PMC board of directors is dedicated to supporting the Coalition’s work to promote the understanding and adoption of personalized medicine concepts, services, and products.
Antonio L. Andreu, M.D., Ph.D.
Scientific Director, EATRIS (European Infrastructure for Translational Medicine)
Cecilia Schott, Pharm.D.
Vice President, Head of Precision Medicine Portfolio Planning, GlaxoSmithKline
Apostolia M. Tsimberidou, M.D., Ph.D.
Professor, Department of Investigational Therapeutics, The University of Texas MD Anderson Cancer Center
Michael J. Vasconcelles, M.D.
Biopharmaceutical Director, Researcher, Advisor, and Entrepreneur, Frazier Life Sciences
